A virtual event by Radcliffe Cardiology
Content for healthcare professionals only
Rhythm Interventions Online
The world's largest virtual arrhythmia event
Content for healthcare professionals only
Symposium – The Power of TRUE Integration
This symposium is supported by J&J Medtech.
0:00 - 01:32 Welcome and Introduction - Giuseppe Ciconte
01:32 - 16:30 Dual Energy: The Best of Both Worlds - Benjamin Berte
16:30 - 31:05 AF Ablation With the Varipulse Safety and Efficacy - Alexandre Almorad
31:05 - 42:10 Optimisation of Both VP & DE STSF During a Day in the Lab - Leon Iden
42:10 - 54:51 Panel Discussion and Q&A - All
During this session, hear from experienced electrophysiologists on the latest pulsed field ablation (PFA) technologies integrated within the CARTOâ„¢ System and how these innovations are being incorporated into clinical workflows. Chaired by Giuseppe Ciconte (Milan, IT), the faculty outline both the supporting clinical evidence and practical considerations for using dual-energy and PFA technologies within the lab on the same day.
Benjamin Berte (Lucerne CH) presents results from the SmartfIRE study, which evaluated the safety and efficacy of the novel dual-energy THERMOCOOL SMARTTOUCHâ„¢ SF catheter for the treatment of drug-refractory, symptomatic paroxysmal atrial fibrillation. The study demonstrated an 86.9% effectiveness rate, highlighting the potential of this approach to achieve durable clinical outcomes.
Additionally, Alexandre Almorad (Brussels, BE) reviews data from the Varipure registry, underscoring the strong safety profile of the Varipulseâ„¢ Platform, including a primary adverse event rate of 0.6% and no reported strokes. These findings provide important real-world insights into the clinical performance of PFA technology.
Finally, Leon Iden (Bad Segeberg, DE) shares how he has integrated both technologies into his lab, detailing workflow strategies, patient selection considerations, and procedural efficiencies observed in routine practice. The session concludes with an engaging panel discussion and audience Q&A.
More 2025 Sessions On-Demand